We use cookies to optimize our website and our service. Read more: Privacy policy.

Skip to content
Medimo.
  • ServicesExpand
    • Pharmacovigilance
    • Quality
    • Auditing
    • Review of promotional material
    • Regulatory affairs
    • Outsourcing
  • The company
  • Personnel
  • Blog
  • Contact us
  • FI

Book here

Medimo.

Blog

A blackout in Spain, a possibility of delay in the Nordics – Why pharmacovigilance must be prepared
Medimo | Pharmacovigilance

A blackout in Spain, a possibility of delay in the Nordics – Why pharmacovigilance must be prepared

July 1, 2025July 1, 2025
Medimo paikallisena lääketurvayhteyshenkilönä
Pharmacovigilance

Medimo’s role as a local pharmacovigilance contact: expert support in ensuring human and veterinary medicine safety

May 26, 2025May 26, 2025
Navigating pharmaceutical marketing rules and regulations
Medimo | Promotional material

Navigating pharmaceutical marketing rules and regulations

April 22, 2025April 22, 2025
Protecting consumers: Why are medicines recalled?
Medimo | Pharmacovigilance

Protecting consumers: Why are medicines recalled?

March 19, 2025March 19, 2025
ATMP Products – The Future of Personalized Medicine.
Medimo | Pharmacovigilance

ATMP products: A new era of medical treatments and Medimo’s expertise

March 6, 2025March 11, 2025
Advanced Therapy Medicinal Products (ATMP) are innovative biopharmaceuticals containing living cells, gene therapy components, or tissues.
Pharmacovigilance

ATMP (Advanced Therapy Medicinal) products and QP role

January 31, 2025March 6, 2025
Myyntilupaseminaari.
Regulatory affairs

Current Insights: Experiences from the Marketing Authorization Seminar 2024

October 18, 2024October 18, 2024
Laituri.
Medimo

Medimo Oy wishes you a wonderful and sunny summer!

June 28, 2024June 28, 2024
Auditointi lääketeollisuudessa.
Auditing | Pharmacovigilance

Inside auditing: Quality assurance of manufacturing and distribution in the pharmaceutical industry

March 7, 2024March 7, 2024
Auditing pharmacovigilance.
Auditing | Pharmacovigilance

Why should pharmacovigilance be audited? Why is it important?

October 23, 2023October 23, 2023

Page navigation

1 2 Next PageNext
EuDRAcon.

We are a member of EuDRAcon: the pan-European network of regulatory affairs consultancy companies dealing with medicinal products, medical devices, cosmetics and food supplements.

Medimo Oy

Näsilinnankatu 27 B
33200 Tampere
Finland

+358 3 389 9000
+358 400 622 800

info@medimo.fi
firstname.lastname@medimo.fi

VAT number: FI32372183
Privacy policy

  • LinkedIn

WebDesign Miia Ylinen.
Scroll to top
  • Medimo
  • Services
    • Pharmacovigilance
    • Quality
    • Auditing
    • Review of promotional material
    • Regulatory affairs
    • Outsourcing
  • The company
  • Personnel
  • Blog
  • Contact us
Search
  • FI